Business Context and Reporting Period
This Form 8-K filing by OrthoPediatrics Corp. (KIDS) covers events occurring on October 18, 2022, with the report dated October 20, 2022. The filing addresses changes to the Company's Board of Directors.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance changes.
Material Changes
- Director Departure: Stephen F. Burns retired from the Board of Directors effective October 18, 2022. The retirement was not the result of any disagreement with the Company.
- Director Appointment: Jimmy D. McDonald was appointed to the Board effective October 18, 2022, to fill the vacancy left by Mr. Burns. His term expires at the 2024 annual shareholder meeting.
- Compensation Adjustment: As part of the retirement agreement, the Board accelerated the vesting of 3,092 remaining shares of restricted stock previously granted to Mr. Burns.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No new risks or contingencies were disclosed in this report. Mr. McDonald is not a party to any transaction requiring disclosure under Item 404(a) of Regulation S-K and has not been appointed to any Board committees to date.
Investor Verification Checklist
- Verify the biographical details and relevant experience of the newly appointed director, Jimmy D. McDonald, in the attached press release (Exhibit 99.1).
- Review the Company's Non-Employee Director Compensation Policy (referenced from the November 4, 2021, 8-K) to understand the pro rata compensation structure for Mr. McDonald.
- Confirm the impact of the accelerated vesting of 3,092 shares on the Company's equity structure and potential dilution.